Hemogenyx Share News (HEMO)

Hemogenyx Information

Buy HEMO Shares
Add HEMO to Watchlist
Add HEMO to Alert

Share Price Information for Hemogenyx (HEMO)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 1.522

Bid: 1.50

Ask: 1.58

Change: 0.015 (0.98%)

Spread: 0.08 (5.333%)

Open: 1.50

High: 1.536

Low: 1.47

Prev. Close: 1.525

Last checked at -

IN BRIEF: Hemogenyx Pharmaceuticals says patent number published

Fri, 08th Sep 2023 19:43

Hemogenyx Pharmaceuticals PLC - London-based biopharmaceutical group developing new therapies and treatments for blood diseases - Says its patent application number "WO2023168292 Chimeric Bait Receptors and Uses Thereof" was published by the World Intellectual Property Organization on Thursday. Says it remains to be reviewed and approved by national patent authorities.

Current stock price: 1.93 pence, up 31% on Friday

12-month change: up 33%

By Harvey Dorset, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

More News

23 Oct 2019 08:41

Hemogenyx Inks USD75,000 Research Deal With Undisclosed Global Firm

30 Sep 2019 16:51

Hemogenyx Interim Loss Widens But CDX Antibody Work Progresses

19 Oct 2018 08:26

Hemogenyx enters collaboration agreement with Orgenesis

(Sharecast News) - Biopharmaceutical group Hemogenyx has entered into a collaboration agreement with cell therapy outfit Orgenesis to further commercialise its humanised-mouse drug model.

15 Oct 2018 08:32

Hemogenyx inks lupus collaboration with Johnson and Johnson

(Sharecast News) - Biopharmaceutical group Hemogenyx has entered into a collaboration agreement industry giant Johnson and Johnson to develop a model of systemic lupus erythematosus, the most common form of Lupus.

3 Apr 2018 13:25

Hemogenyx Pharmaceuticals Appoints Marc Feldmann As Executive Chairman

LONDON (Alliance News) - Biotechnology company Hemogenyx Pharmaceuticals PLC said on Tuesday it has appointed Marc Feldmann as executive chairman, with effect next will be who

Latest Share Chat

Hemogenyx Share News (HEMO)

Share Price Information for Hemogenyx (HEMO)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Hemogenyx Pharmaceuticals says patent number published

Hemogenyx Inks USD75,000 Research Deal With Undisclosed Global Firm

Hemogenyx Interim Loss Widens But CDX Antibody Work Progresses

Hemogenyx enters collaboration agreement with Orgenesis

Hemogenyx inks lupus collaboration with Johnson and Johnson

Hemogenyx Pharmaceuticals Appoints Marc Feldmann As Executive Chairman

Login to your account

Quickpicks are a member only feature

Login to your account